Evidence map›Paper›PMID 27405449›Full record

ArticleScientific reports2016

Reduced TRMU expression increases the sensitivity of hair-cell-like HEI-OC-1 cells to neomycin damage in vitro.

Zuhong He, Shan Sun, Muhammad Waqas, Xiaoli Zhang, Fuping Qian, Cheng Cheng, Mingshu Zhang, Shasha Zhang, Yongming Wang, Mingliang Tang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. [Progress in genetic susceptibility to aminoglycoside-induced deafness].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2021
    Review
  14. Article
  15. Article
  16. Molecular Behavior of HMGB1 in the Cochlea Following Noise Exposure andFrontiers in cell and developmental biology · 2021
    Article
  17. Frontiers in cell and developmental biology · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Zuhong HeState Key Laboratory of Bioelectronics, Institute of Life Sciences, Southeast University, Nanjing 210096, China.
Shan SunDepartment of Otorhinolaryngology, Hearing Research Institute, Affiliated Eye and ENT Hospital of Fudan University, Shanghai 200031, China.
Muhammad WaqasState Key Laboratory of Bioelectronics, Institute of Life Sciences, Southeast University, Nanjing 210096, China.
Xiaoli ZhangDepartment of Otolaryngology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China.
Fuping QianState Key Laboratory of Bioelectronics, Institute of Life Sciences, Southeast University, Nanjing 210096, China.
Cheng ChengState Key Laboratory of Bioelectronics, Institute of Life Sciences, Southeast University, Nanjing 210096, China.
Mingshu ZhangMedical School, Southeast University, Nanjing 210096, China.
Shasha ZhangState Key Laboratory of Bioelectronics, Institute of Life Sciences, Southeast University, Nanjing 210096, China.
Yongming WangInstitutes of Life Sciences, Fudan University, Shanghai 200032, China.
Mingliang TangState Key Laboratory of Bioelectronics, Institute of Life Sciences, Southeast University, Nanjing 210096, China.
Huawei LiDepartment of Otorhinolaryngology, Hearing Research Institute, Affiliated Eye and ENT Hospital of Fudan University, Shanghai 200031, China.
Renjie ChaiState Key Laboratory of Bioelectronics, Institute of Life Sciences, Southeast University, Nanjing 210096, China.
Southeast University · CNNantong University · CNEye & ENT Hospital of Fudan University · CNFudan University · CNNanjing Drum Tower Hospital · CNState Key Laboratory of Digital Medical Engineering

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aminoglycosides are ototoxic to the cochlear hair cells, and mitochondrial dysfunction is one of the major mechanisms behind ototoxic drug-induced hair cell death. TRMU (tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase) is a mitochondrial protein that participates in mitochondrial tRNA modifications, but the role of TRMU in aminoglycoside-induced ototoxicity remains to be elucidated. In this study, we took advantage of the HEI-OC-1 cell line to investigate the role of TRMU in aminoglycoside-induced cell death. We found that TRMU is expressed in both hair cells and HEI-OC-1 cells, and its expression is significantly decreased after 24 h neomycin treatment. We then downregulated TRMU expression with siRNA and found that cell death and apoptosis were significantly increased after neomycin injury. Furthermore, when we down-regulated TRMU expression, we observed significantly increased mitochondrial dysfunction and increased levels of reactive oxygen species (ROS) after neomycin injury, suggesting that TRMU regulates mitochondrial function and ROS levels. Lastly, the antioxidant N-acetylcysteine rescued the mitochondrial dysfunction and cell apoptosis that was induced by TRMU downregulation, suggesting that ROS accumulation contributed to the increased aminoglycosides sensitivity of HEI-OC-1 cells after TRMU downregulation. This study provides evidence that TRMU might be a new therapeutic target for the prevention of aminoglycoside-induced hair cell death.

Indexed as

AcetylcysteineAnimalsApoptosisCell LineCell SurvivalDown-RegulationHair Cells, AuditoryIn Vitro TechniquesMiceMitochondriaNeomycinReactive Oxygen SpeciestRNA MethyltransferasesAcetylcysteineNeomycinReactive Oxygen SpeciestRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase 1, mousetRNA Methyltransferases

Identifiers

PMID27405449
PMCPMC4942793
OpenAlexW2473915971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.